10 Best Small Cap Stocks To Own For 2016: Achillion Pharmaceuticals Inc.(ACHN)
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidates for the treatment of chronic HCV include ACH-1625, a protease inhibitor, which is in phase IIa clinical trial for the treatment of chronic HCV; ACH-2684, a pangenotypic protease inhibitor, which is in phase I clinical trial for the treatment of chronic HCV infection; and NS5A inhibitors for the treatment of chronic HCV infection, including ACH-2928, which is to enter a phase I clinical trial, as well as various additional NS5A inhibitors in preclinical development. Its pipeline of product candidates also includes ACH-702 and ACH-2881 for drug resistant bacterial infections; elvucitabine for HIV infection; and AC H-1095 for HCV infection. The company was founded in 1998 and is based in New Haven, Connecticut.
Advisors' Opinion:- [By Ben Levisohn]
Achillion Pharmaceuticals (ACHN) has advanced2.2% to $11.82 after its target was raised to $15 from $11 at UBS.
Regeneron Pharmaceuticals (REGN) has gained 1.2% to354.81 after its target price was raised to $400 from $340 at Credit Suisse.
- [By Keith Speights]
Hold horrors
Achillion Pharmaceuticals (NASDAQ: ACHN ) takes the worst spot this week. Shares plunged 62% on bad news from the U.S. Food and Drug Administration.
source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/10-best-small-cap-stocks-to-own-for-2016.html
No comments:
Post a Comment